News
-
-
PRESS RELEASE
Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses
Xenetic Biosciences presents promising findings on combining DNase I with CAR T cells to enhance cancer treatment strategies at the SITC Spring Scientific 2025 Cell Therapy Meeting -
-
-
PRESS RELEASE
Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting
Xenetic Biosciences announces abstract acceptance for SITC Spring Scientific 2025 Cell Therapy Meeting on targeting Neutrophil Extracellular Traps in Metastatic Melanoma -
-
-
-
-